Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Blood. 2018 Nov 29;132(22):2375-2388. doi: 10.1182/blood-2017-09-804401. Epub 2018 Sep 4.
Genomic studies have recently identified as a new driver gene in aggressive and chemorefractory cases of chronic lymphocytic leukemia (CLL). encodes a ribosomal protein whose conserved C-terminal domain extends into the decoding center of the ribosome. We demonstrate that mutations in highly conserved residues of this domain affect protein stability, by increasing its ubiquitin-mediated degradation, and cell-proliferation rates. On the other hand, we show that mutated RPS15 can be loaded into the ribosomes, directly impacting on global protein synthesis and/or translational fidelity in a mutation-specific manner. Quantitative mass spectrometry analyses suggest that variants may induce additional alterations in the translational machinery, as well as a metabolic shift at the proteome level in HEK293T and MEC-1 cells. These results indicate that CLL-related RPS15 mutations might act following patterns known for other ribosomal diseases, likely switching from a hypo- to a hyperproliferative phenotype driven by mutated ribosomes. In this scenario, loss of translational fidelity causing altered cell proteostasis can be proposed as a new molecular mechanism involved in CLL pathobiology.
基因组研究最近将 鉴定为慢性淋巴细胞白血病(CLL)侵袭性和化疗耐药病例中的一个新的驱动基因。 编码核糖体蛋白,其保守的 C 端结构域延伸到核糖体的解码中心。我们证明,该结构域中高度保守残基的突变通过增加其泛素介导的降解而影响蛋白质稳定性,并影响细胞增殖率。另一方面,我们表明突变的 RPS15 可以被加载到核糖体中,以突变特异性的方式直接影响全局蛋白质合成和/或翻译保真度。定量质谱分析表明, 变体可能会在翻译机制中引起额外的改变,以及在 HEK293T 和 MEC-1 细胞中蛋白质组水平的代谢转变。这些结果表明,与 CLL 相关的 RPS15 突变可能遵循其他核糖体疾病已知的模式起作用,可能由突变核糖体驱动从低增殖表型转变为高增殖表型。在这种情况下,可以提出导致细胞蛋白质稳态改变的翻译保真度丧失作为 CLL 病理生物学中涉及的新分子机制。